Hiroki Ueyama

Sep 12, 2024 | jacc.org | Hiroki Ueyama |Kevin Kennedy |Jennifer A. Rymer |Alexander T. Sandhu

References1. "2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: executive summary". J Am Coll Cardiol . 2014;64:2645-2687. 2. "Timing, selection, modulation, and duration of P2Y12 inhibitors for patients with acute coronary syndromes undergoing PCI". JACC Cardiovasc Interv . 2023;16:1-18. 3. "Pre-treatment with oral P2Y12 inhibitors in non-ST-segment elevation acute coronary syndromes: does one size fit all?"JACC Cardiovasc Interv . 2020;13:918-920. 4.

Jun 4, 2024 | onlinelibrary.wiley.com | Hiroki Ueyama |Peter Block

Corresponding Author Peter C. Block MD, MSCAI Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA Correspondence Peter C. Block, MD, MSCAI, Emory University, Atlanta, GA, USA. Email: [email protected] for more papers by this author

Dec 29, 2023 | onlinelibrary.wiley.com | Tetsuya Saito |Toshiki Kuno |Albert Einstein College |Hiroki Ueyama

Corresponding Author Toshiki Kuno MD, PhD, FESC, FSCAI Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA Division of Cardiology, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA Correspondence Toshiki Kuno, MD, PhD, FESC, FSCAI, Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th St, Bronx, NY 10467–2401, USA.